文献类型：期刊文献

英文题名：Comparison and trend analysis of cancer incidence in China and globally in 2022

作者：Hu, Dan[1];Yu, Jiang[2];Feng, Jiao[1];Liu, Ping[3];Chen, Ji-Ming[1];Zhang, Hao-Ling[4,5]

第一作者：Hu, Dan

通信作者：Chen, JM[1];Zhang, HL[2];Zhang, HL[3]

机构：[1]Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Key Lab Child Dev & Disorders, Dept Oral Ophthalmol,Childrens Hosp,Minist Educ,Ch, 136 Zhongshan 2nd Rd, Chongqing 400014, Peoples R China;[2]Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing 400016, Peoples R China;[3]Sichuan Univ, Dept Crit Care Med, West China Hosp, Chengdu 610041, Sichuan, Peoples R China;[4]Univ Sains Malaysia, Adv Med & Dent Inst, Dept Biomed Sci, George Town 13200, Penang, Malaysia;[5]Gansu Univ Chinese Med, Sch Publ Hlth, Lanzhou 730000, Gansu, Peoples R China

第一机构：Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Key Lab Child Dev & Disorders, Dept Oral Ophthalmol,Childrens Hosp,Minist Educ,Ch, 136 Zhongshan 2nd Rd, Chongqing 400014, Peoples R China

通信机构：[1]corresponding author), Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Key Lab Child Dev & Disorders, Dept Oral Ophthalmol,Childrens Hosp,Minist Educ,Ch, 136 Zhongshan 2nd Rd, Chongqing 400014, Peoples R China;[2]corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Dept Biomed Sci, George Town 13200, Penang, Malaysia;[3]corresponding author), Gansu Univ Chinese Med, Sch Publ Hlth, Lanzhou 730000, Gansu, Peoples R China.|[10735e9d5e7087247e71b]甘肃中医药大学公共卫生学院;[10735]甘肃中医药大学;

年份：2025

卷号：16

期号：6

外文期刊名：WORLD JOURNAL OF CLINICAL ONCOLOGY

收录：WOS:【ESCI(收录号:WOS:001517166400010)】；

语种：英文

外文关键词：Cancer burden; Neoplasms; Cancer registry; Incidence; Epidemiology

摘要：In April 2024, the International Agency for Research on Cancer (IARC) published the 2022 Global Cancer Statistics Report in CA: A Cancer Journal for Clinicians, focusing on the incidence of 36 kinds of cancers in 185 countries or regions around the world, different gender, geographical area and Human Development Index differences in different economic regions. Previously, China's National Cancer Center (NCC) collaborated with IARC to estimate China's cancer incidence data using actual and up-to-date surveillance data from China. This collaboration aimed to ensure consistency between the cancer burden data published by IARC and NCC. In February of the same year, the NCC released the latest estimated statistics regarding the cancer incidence in China for 2022 in the Journal of the National Cancer Center. This research seeks to gather and evaluate the latest reports on cancer incidence from both a global perspective and within China for the year 2022. By conducting a multi-dimensional analysis of cancer incidence patterns, gender distribution, geographic spread, and trends over time, the study highlights the distinctions in the burden of malignant tumors between China and the global scenario. Additionally, it explores the risk factors associated with high-incidence cancer types and examines the current status of prevention and control measures. The findings aim to serve as a valuable reference for developing effective cancer prevention and control strategies in China.